Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Customized computed tomography-based boost volumes in breast-conserving therapy: use of three-dimensional histologic information for clinical target volume margins.
Hanbeukers B, Borger J, van den Ende P, van der Ent F, Houben R, Jager J, Keymeulen K, Murrer L, Sastrowijoto S, van de Vijver K, Boersma L. Hanbeukers B, et al. Among authors: keymeulen k. Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):757-63. doi: 10.1016/j.ijrobp.2008.11.048. Epub 2009 Mar 21. Int J Radiat Oncol Biol Phys. 2009. PMID: 19304402
Breast magnetic resonance imaging use in patients undergoing neoadjuvant chemotherapy is associated with less mastectomies in large ductal cancers but not in lobular cancers.
Vriens IJH, Keymeulen K, Lobbes MBI, van Bommel ACM, Nieuwenhuijzen GAP, Smidt ML, Boersma LJ, van Dalen T, Smorenburg CH, Struikmans H, Siesling S, Voogd AC, Tjan-Heijnen VCG; National Breast Cancer Organization of the Netherlands – Breast Cancer Audit Scientific Committee (NBCA). Vriens IJH, et al. Among authors: keymeulen k. Eur J Cancer. 2017 Aug;81:74-80. doi: 10.1016/j.ejca.2017.05.012. Epub 2017 Jun 12. Eur J Cancer. 2017. PMID: 28618304
A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer.
Brandão RD, Veeck J, Van de Vijver KK, Lindsey P, de Vries B, van Elssen CH, Blok MJ, Keymeulen K, Ayoubi T, Smeets HJ, Tjan-Heijnen VC, Hupperets PS. Brandão RD, et al. Among authors: keymeulen k. Breast Cancer Res. 2013 Apr 8;15(2):R29. doi: 10.1186/bcr3409. Breast Cancer Res. 2013. PMID: 23566419 Free PMC article. Clinical Trial.
53 results